These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2199202)

  • 21. Influence of gliclazide on glucose-stimulated insulin release in man.
    van Haeften TW; Veneman TF; Gerich JE; van der Veen EA
    Metabolism; 1991 Jul; 40(7):751-5. PubMed ID: 1870430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute actions of sulfonylurea drugs during long-term treatment of NIDDM.
    Faber OK; Beck-Nielsen H; Binder C; Butzer P; Damsgaard EM; Froland F; Hjollund E; Lindskov HO; Melander A; Pedersen O
    Diabetes Care; 1990 Aug; 13 Suppl 3():26-31. PubMed ID: 2120020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliclazide: the effects on lipids in type II diabetes.
    Delargy M; McGovern M; Johnson A; Tomkin GH
    Ir J Med Sci; 1985 Mar; 154(3):102-5. PubMed ID: 3997441
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metabolic effects of gliclazide in diabetes type II patients. Study with indirect calorimetry].
    Golay A; Broquet C; Chabot V; Studer S; Felber JP
    Schweiz Med Wochenschr; 1984 Feb; 114(8):261-4. PubMed ID: 6369531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM.
    Gannon MC; Ercan N; Westphal SA; Nuttall FQ
    Diabetes Care; 1993 Jun; 16(6):874-80. PubMed ID: 8325201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up.
    Quatraro A; Consoli G; Ceriello A; Giugliano D
    Diabete Metab; 1986 Dec; 12(6):315-8. PubMed ID: 3545931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.
    Ahrén B; Scherstén B
    Acta Med Scand; 1984; 215(5):487-91. PubMed ID: 6430037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetes.
    Scott RS; Donnelly T
    Diabetes Res Clin Pract; 1987; 3(3):175-8. PubMed ID: 3595434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects.
    Ward G; Harrison LC; Proietto J; Aitken P; Nankervis A
    Diabetes; 1985 Mar; 34(3):241-5. PubMed ID: 3882491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term effect of gliclazide on platelet function in diabetes].
    Pan CY
    Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):233-5. PubMed ID: 6432285
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of the combination of insulin and gliclazide compared with insulin alone in type 2 diabetic patients with secondary failure to oral hypoglycemic agents.
    Aschner P; Kattah W
    Diabetes Res Clin Pract; 1992 Oct; 18(1):23-30. PubMed ID: 1446575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications.
    Sinay IR; Arias P; Schnitman MA; Damilano SA; Faingold MC; Moguilevsky JA
    Acta Diabetol Lat; 1988; 25(4):289-97. PubMed ID: 3072813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes.
    McAlpine LG; McAlpine CH; Waclawski ER; Storer AM; Kay JW; Frier BM
    Eur J Clin Pharmacol; 1988; 34(2):129-32. PubMed ID: 3289948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gliclazide on plasma lipids and pancreatic beta cell function in non-insulin-dependent diabetes mellitus.
    Chen KW; Juang JH; Huang HS; Lin JD; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):246-50. PubMed ID: 8313208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Home blood glucose monitoring in non-insulin-dependent diabetics: the effect of gliclazide on blood glucose and weight control, a multicentre trial.
    Shaw KM; Wheeley MS; Campbell DB; Ward JD
    Diabet Med; 1985 Nov; 2(6):484-90. PubMed ID: 2951123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic].
    Brogard JM; Pinget M; Leconte A; Dorner M
    Rev Med Interne; 1982 Dec; 3(4):379-87. PubMed ID: 6761818
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypoglycemic and microvascular properties of gliclazide: a review of the latest international studies].
    Lesobre B
    Sem Hop; 1983 Jun; 59(24):1827-33. PubMed ID: 6308816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.
    Guillausseau PJ; Greb W
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):133-7. PubMed ID: 11353879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.